230 related articles for article (PubMed ID: 33062071)
1. Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Dong Y; Ma G; Liu Y; Lu S; Liu L
Dis Markers; 2020; 2020():8842795. PubMed ID: 33062071
[TBL] [Abstract][Full Text] [Related]
2. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral vessel density as prognostic factors in head and neck squamous cell carcinoma: a meta-analysis of literature.
Yu M; Liu L; Liang C; Li P; Ma X; Zhang Q; Wei Y
Head Neck; 2014 Apr; 36(4):596-602. PubMed ID: 23780885
[TBL] [Abstract][Full Text] [Related]
5. Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.
Li B; Chen M; Pan MX
J Cancer Res Ther; 2020; 16(3):434-439. PubMed ID: 32719247
[TBL] [Abstract][Full Text] [Related]
6. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Yang L; Huang Y; Zhou L; Dai Y; Hu G
Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
[TBL] [Abstract][Full Text] [Related]
9. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
Wei D; Liu J; Ma J
PeerJ; 2023; 11():e16014. PubMed ID: 37719125
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
Cho JK; Lee GJ; Kim HD; Moon UY; Kim MJ; Kim S; Baek KH; Jeong HS
PLoS One; 2018; 13(9):e0203758. PubMed ID: 30192876
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
Zhu Y; Liu H; Xie N; Liu X; Huang H; Wang C; Hou J
Head Neck; 2019 Feb; 41(2):542-550. PubMed ID: 30549142
[TBL] [Abstract][Full Text] [Related]
12. Perineural invasion as a prognostic factor in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Zhu J; Zhou R; Wang Y; Yu M
Acta Otolaryngol; 2019 Nov; 139(11):1038-1043. PubMed ID: 31464544
[No Abstract] [Full Text] [Related]
13. Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
Wan Y; Liu H; Zhang M; Huang Z; Zhou H; Zhu Y; Tao Y; Xie N; Liu X; Hou J; Wang C
Head Neck; 2020 May; 42(5):1067-1076. PubMed ID: 32048783
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis.
Tang WH; Sun W; Long GX
Medicine (Baltimore); 2020 Sep; 99(36):e21785. PubMed ID: 32899005
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis.
Hu Y; Ai LS; Zhou LQ
PLoS One; 2021; 16(5):e0251202. PubMed ID: 33989301
[TBL] [Abstract][Full Text] [Related]
16. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
[TBL] [Abstract][Full Text] [Related]
18. Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Luan CW; Kuo LT; Wang YT; Liao CT; Kang CJ; Lee YC; Chen KY; Lai CH; Tsai YH; Huang EI; Tsai MS; Hsu CM; Chang GH; Tsai YT
Head Neck; 2023 Jul; 45(7):1856-1867. PubMed ID: 37161915
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
Bueno de Oliveira T; Camila Braun A; Ribaldo Nicolau U; Ali Abdallah E; da Silva Alves V; Hugo Fonseca de Jesus V; Fernando Calsavara V; Paulo Kowaslki L; Domingos Chinen LT
Oral Oncol; 2021 Oct; 121():105480. PubMed ID: 34403888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
